Abstract B023: Fibulin-3 promotes tumor progression and microenvironment remodeling in CA19-9-expressing pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignancies, with a five-year survival rate below 13%. Although carbohydrate antigen 19-9 (CA19-9) is widely used as a prognostic biomarker for PDA, the functional roles of CA19-9-modified proteins in driving tumor progression remain poorly understood....